Black Diamond Therapeutics Competitors and Similar CompaniesClear all

Black Diamond Therapeutics's competitors and similar companies include Takeda, Biocon, Shanghai Junshi Biosciences and Kyowa Kirin.
Black Diamond Therapeutics
Black Diamond Therapeutics
Black Diamond Therapeutics is a biotechnology company.
Takeda
Takeda
Takeda Pharmaceutical is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.
Biocon
Biocon
Biocon is a global biopharmaceutical company.
Shanghai Junshi Biosciences
Shanghai Junshi Biosciences
Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases.
Kyowa Kirin
Kyowa Kirin
Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system.
Founding Date
Founding Date
2017
Founding Date
1781
Founding Date
1978
Founding Date
2012
Founding Date
2008
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Cambridge, US HQ
Toronto, CA
New York, US
Stony Brook, US
Locations
Tokyo, JP HQ
Buenos Aires, AR
The Rocks, AU
Linz, AT
Wien, AT
Wien, AT
Lessines, BE
see more
Locations
Bengaluru, IN HQ
Bengaluru, IN
Hyderabad, IN
Visakhapatnam, IN
Dublin, IE
Kuala Lumpur, MY
Puchong, MY
see more
Locations
Shanghai, CN HQ
Locations
Tokyo, JP HQ
Sydney, AU
Shanghai, CN
Prague, CZ
Tampere, FI
Düsseldorf, DE
Hong Kong, HK
see more
Employees
Employees
6526% decrease
Employees
49,095
Employees
16,545
Employees
2,961
Employees
5,974
Valuation ($)
Valuation ($)
262.2 m
Valuation ($)
42.5 b
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
9.5 b

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
N/A
Revenue (est.)
₹109.3b (FY, 2023)
Revenue (est.)
¥1.5b (FY, 2023)
Revenue (est.)
¥398.4b (FY, 2022)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
₹39.3b (FY, 2023)
Cost of goods
¥541m (FY, 2023)
Cost of goods
¥78.5b (FY, 2022)
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
₹78.5b (FY, 2023)
Gross profit
¥941.9m (FY, 2023)
Gross profit
¥321.6b (FY, 2022)
Net income
Net income
($82.4m) (FY, 2023)
Net income
N/A
Net income
₹6.4b (FY, 2023)
Net income
(¥2.5b) (FY, 2023)
Net income
¥53.6b (FY, 2022)

Funding

Total funding raised
Total funding raised
$ 202.1m
Total funding raised
$ 57.8m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Takeda
HQ
Tokyo, JP
Employees
49,095

Takeda Pharmaceutical is a biopharmaceutical company engaged in the research, development, production, and commercialization of pharmaceutical products.

View company
Biocon
HQ
Bengaluru, IN
Employees
16,545

Biocon is a global biopharmaceutical company.

View company
Shanghai Junshi Biosciences
HQ
Shanghai, CN
Employees
2,961

Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases.

View company
Kyowa Kirin
HQ
Tokyo, JP
Employees
5,974

Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system.

View company